Best radiographic response to nivolumab and relatlimab in colorectal cancer, indicating the role of T cell density.
Supplementary Figure 5. Best radiographic response to relatlimab and nivolumab in patients with microsatellite stable colorectal cancer stratified by pre-treatment cytotoxic T cell (A) and Treg (B) density.
No takes yet. Share an insight, caveat, or question.
Christenson et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: